As I expect you already realise, this phase 1b is also superior to the previous Phase 1b tests in that it's Active Drug v Alternate v Placebo in the same patient. When I last spoke to Matt he emphasised this and the value it represents to pharmas (not farmers, though it could be..), due to the robustness of data this type of test will supply (e.g. eliminates variability between patients).
in other words, these upcoming Phase 1b results will be the most valuable to date, and if (as expected) they're positive, should also have a significant impact on the SP.
And then it's countdown for Phase 2 (& JVs & buyouts..?)
Bot Chart, page-124
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.5¢ |
Change
0.020(7.84%) |
Mkt cap ! $433.1M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 27.5¢ | 25.5¢ | $863.9K | 3.224M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 553516 | 26.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.5¢ | 51243 | 2 |
View Market Depth
| Last trade - 16.10pm 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
27.0¢ |
Change
0.020 ( 5.30 %) |
||||
| Open | High | Low | Volume | ||
| 26.0¢ | 27.5¢ | 26.0¢ | 975200 | ||
| Last updated 16.00pm 16/05/2024 ? | |||||
| BOT (ASX) Chart |